查詢結果分析
來源資料
相關文獻
- Transurethral Prostatic Resection for Acute Urinary Retention in Patients with Prostate Cancer
- Flutamide-Induced Liver Injury: A Case Report
- 攝護腺癌之化學藥物治療
- 攝護腺癌的放射線治療及其護理
- Free-to-total Serum Prostate Specific Antigen Ratio in Chinese Men
- 從末期攝護腺癌及乳癌來探討癌症病患荷爾蒙治療法之進展
- Detection of Prostatic Cancer Using Digital Rectal Examination, Prostate-Specific Antigen and Transrectal Ultrasonography
- Use of a Medical Decision Support System to Improve the Preoperative Diagnosis of Prostate Cancer with Pelvic Lymph Node Metastases
- Prostatic Carcinoma Presenting as Rectal Stenosis--A Case Report
- 攝護腺肥大患者之潛伏攝護腺癌
頁籤選單縮合
題 名 | Transurethral Prostatic Resection for Acute Urinary Retention in Patients with Prostate Cancer=攝護腺癌病患因急性尿滯留接受經尿道攝護腺切除手術 |
---|---|
作 者 | 張彰琦; 郭俊逸; 陳光國; 林登龍; 張延驊; 吳宏豪; 張心湜; | 書刊名 | 中華醫學會雜誌 |
卷 期 | 69:1 民95.01 |
頁 次 | 頁21-25+CA04 |
分類號 | 416.275 |
關鍵詞 | 攝護腺癌; 經尿道攝護腺切除手術; 尿滯留; Prostate cancer; Transurethral prostate resection; Urinary retention; |
語 文 | 英文(English) |
英文摘要 | Background: Few studies have focused on clinical findings in prostate cancer patients receiving transurethral resection of the prostate (TURP) for acute urinary retention (AUR). We compared the clinical findings (preoperative characteristics, operative morbidities, and pathology results) of patients with diagnosed prostate cancer undergoing palliative TURP for AUR with those of patients undergoing TURP for AUR who were diagnosed with prostate cancer postoperatively. Methods: The charts of 25 patients with prostate cancer undergoing TURP for AUR between 1986 and 2003 were retrospectively reviewed. Fourteen patients underwent palliative TURP (group A) and the other 11 patients with newly diagnosed prostate cancer received TURP (group B). The data, including preoperative characteristics, operative morbidities, and pathology results were analyzed. Results: There were no significant differences between the 2 groups in parameters such as age at diagnosis and operation, operative time, hospitalization, and catheter duration. However, the Gleason score was higher in group A (7.6 E 1.7) than in group B (5.4 E 1.8) (p < 0.005). The mean resected weight was lower in group A (19.9 g) than in group B (39.5 g). Group A was more likely to receive recatheterization (33.3% vs 0%, p = 0.058) and repeat operation (28.6%), although the difference was not statistically significant. There were no complications such as transurethral resection syndrome or perioperative death in either group. Conclusion: TURP can be performed safely for relief of AUR in patients with prostate cancer, no matter if the cancer was diagnosed before or after surgery. The higher Gleason score and more advanced cancer stage, as found in group A, may correlate to high recatheterization and reoperation rates due to preexisting tumor progression. |
本系統中英文摘要資訊取自各篇刊載內容。